首页> 外国专利> Use of triterpensaponins, such as notoginsenoside R1 (NR1) and/or astragaloside (ASIV) for preparing medicaments

Use of triterpensaponins, such as notoginsenoside R1 (NR1) and/or astragaloside (ASIV) for preparing medicaments

机译:三萜皂苷,例如三七皂苷R1(NR1)和/或黄芪甲苷(ASIV)在制备药物中的用途

摘要

The use of triterpensaponins, like notoginsenoside R1 (NR1) and/or astragaloside (ASIV) for the production of medicaments for stimulating the fibrinolytic activity and blocking the endotoxin effect, especially for the treatment of patients and animals which suffer from endotoxin shock or to limit the endotoxin shock. Corresponding medicaments are also suitable prophylactive and therapeutic treatment of patients of coronary heart disease, peripheral arterial disease for patients who suffer from angina pectoris and for the prevention of such diseases in healthy persons.
机译:三萜皂苷,如三七皂苷R1(NR1)和/或黄芪甲苷(ASIV)在生产用于刺激纤溶活性和阻断内毒素作用的药物中的用途,尤其是用于治疗内毒素休克或极限内毒素的患者和动物内毒素休克。相应的药物也适合患有冠心病的患者的冠心病,外周动脉疾病的患者的预防和治疗,以及在健康人中预防此类疾病。

著录项

  • 公开/公告号US5770578A

    专利类型

  • 公开/公告日1998-06-23

    原文格式PDF

  • 申请/专利权人 BERGI GMBH;

    申请/专利号US19960553611

  • 发明设计人 BERND BINDER;WEIJIAN ZHANG;JOHANN WOJTA;

    申请日1996-01-04

  • 分类号A61K31/705;

  • 国家 US

  • 入库时间 2022-08-22 02:39:17

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号